TARO
Taro Pharmaceutical Industries Ltd.
TARO
TARO
Delisted
TARO was delisted on the 21st of June, 2024.
70 hedge funds and large institutions have $130M invested in Taro Pharmaceutical Industries Ltd. in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 19 increasing their positions, 27 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Holders
70
Holding in Top 10
1
Calls
–
Puts
$2K
Top Buyers
| 1 | +$2.44M | |
| 2 | +$775K | |
| 3 | +$540K | |
| 4 |
BlackRock
New York
|
+$427K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$347K |
Top Sellers
| 1 | -$1.12M | |
| 2 | -$1.02M | |
| 3 | -$544K | |
| 4 |
HF
HRT Financial
New York
|
-$527K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$409K |